Loading clinical trials...
Loading clinical trials...
Mesothelin/GPC3/GUCY2C Targeted CAR-T for Immunotherapy of Pancreatic Cancer: Phase I Clinical Trial
Conditions
Interventions
CAR-T cells
Locations
1
China
The Second Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Start Date
March 10, 2023
Primary Completion Date
March 10, 2029
Completion Date
March 10, 2036
Last Updated
June 25, 2024
NCT04485286
NCT04605913
NCT06051695
NCT06242470
NCT05679674
NCT06545942
Lead Sponsor
Second Affiliated Hospital of Guangzhou Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions